This was a retrospective review of patients undergoing reconstruction with the PTO flap following ELAPE. Data included patients' demographics, neo-adjuvant chemo-radiotherapy, histopathology, duration of surgery, follow-up period and complications.
INTRODUCTION:
Rectovaginal and rectourethral fistulas can occur secondary to obstetric complications, cancer and radiation, inflammatory bowel disease, and previous surgery. They are highly distressing to the patient and are often refractory to treatment. Flap reconstruction places vascularized tissue between the apertures, creating separation and aiding in healing. This is particularly useful for complex cases refractory to standard techniques. The purpose of this study was to investigate the outcomes of flap reconstruction of rectovaginal and rectourethral fistulas in the setting of complicating comorbidities at all three Mayo Clinic sites over a 20-year period.
METHODS:
All patients at all Mayo Clinic hospitals who underwent flap reconstruction of a rectovaginal or rectourethral fistula between January 1995 and December 2014 were identified. Patient demographics, surgical indications, and comorbidities were collected. Operative and postoperative data were also collected, including flap type, length of hospital stay, 30-day complications, recurrences, and follow-up time. Operative success was defined as definitive treatment of the fistula without recurrence within 6 months.
RESULTS:
There were 59 patients who underwent 66 reconstructions. The 30-day postoperative complication rate was 59.1% across all patients, primarily consisting of infection (13) and dehiscence (11), with 1 partial flap loss and no mortality. The 6-month success rate was 51.5% across all patients. Patients with fistula secondary to obstetric complications had significantly lower success rates (11.1%, p=0.031). Flap success rate for obstetric patients was significantly lower than for patients undergoing flap reconstruction secondary to cancer treatment (p=0.045), but not for bowel disease (p=0.051). There were no other statistically significant differences in outcomes by etiology, history of radiation, flap type, gender, or history of prior repair attempt.
CONCLUSION:
Flap reconstruction remains a valuable treatment option for complex or refractory rectovaginal, rectourethral, and other GI-togenitourinary or complex genitourinary-perineal fistulas. Many different flaps, including low-morbidity options such as gracilis and Martius-type flaps, can successfully be used as first-line reconstructive options. Despite an initial success rate of 50%, nearly all cases were able to be repaired after a single additional reconstructive procedure. Patients with GI-to-vaginal fistulas due to obstetric complications had significantly lower success rates, suggesting that these patients may require more aggressive flap options.
